Earum Pharmaceuticals Ltd - 542724 - Board Meeting Outcome for Outcome Of Board Meeting Held Today I.E.14Th July, 2022
Pursuant to second proviso to Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Board of Directors of the Company, in their meeting held today, i.e. on 14th July, 2022, at the Registered Office of the Company, which commenced at 4:00 P.M. and concluded at 5:15 P.M. inter-alia, has to Consider and approve the Unaudited Financial Results of the Company for the Quarter ended on 30th June, 2022 along with Limited Review Report. Kindly take the same on your record and oblige us. Thanking You14-07-2022